Genasys INC

Genasys Inc. announced preliminary fiscal third quarter 2026 results, anticipating revenue between $7.0-$7.5 million, with gross margins of 55-58% and an adjusted EBITDA loss of ($3.0)-($3.3) million, citing supply chain and payment delays impacting current quarter performance but expecting a strong finish to the year.

Genasys Inc. announced a Third Amendment to its Term Loan and Security Agreement, extending the loan maturity to July 2027 and amending warrant terms, aiming to provide financial flexibility for growth.

Genasys Inc. announced fiscal second quarter 2026 results, showcasing a significant return to profitability with $0.7 million net income and a gross margin exceeding 63%, driven by increased revenue and operational efficiencies.

Genasys appointed veteran executive Larry Hagenbuch to its Board and as Audit Committee Chair, highlighting growth opportunities and noting potential capital needs.

Genasys Inc. announced the results of its 2026 Annual Meeting of Stockholders, where all director nominees were elected, the independent auditor was ratified, and executive compensation received advisory approval.

Genasys Inc. details CEO Richard Danforth's 2026 fiscal year compensation, including base salary, performance-based cash bonuses, and restricted stock units.

Genasys Inc. announced a significant increase in first-quarter revenue and a substantial reduction in net loss, driven by strong hardware sales and the Puerto Rico EWS Project.

Genasys Inc. reported a 37.5% increase in total revenues for the nine months ended June 30, 2025, driven by strong hardware and software sales, while narrowing its net loss despite a decline in gross profit margin and significant increase in liabilities.

Genasys Inc. announces an amendment to its term loan agreement, securing additional financing to support operations and growth initiatives despite a net loss for the quarter.

Genasys Inc. saw a significant revenue increase in the first quarter of fiscal year 2025, driven by both hardware and software sales, but the company still reported a net loss.

Genasys Inc. reported a decrease in revenue for the third quarter of 2024, primarily due to lower hardware sales, while software revenue showed growth and the company continues to invest in its Genasys Protect platform.

Genasys Inc. experienced a significant decrease in revenue for the second quarter of 2024, primarily due to lower hardware sales, while software revenue showed growth, and the company secured a $15 million loan to support operations.

Genasys Inc. announced a significant increase in revenues and a substantial reduction in net loss for fiscal year 2025, driven by hardware sales and recurring software growth, despite ongoing operational challenges.

Genasys Inc. has filed an amendment to its annual report on Form 10-K for the fiscal year ended September 30, 2024, solely to include a conformed signature on Exhibit 32.1.

Genasys Inc. reported its fiscal year 2024 results, showing a decrease in hardware revenue offset by growth in software revenue and strategic acquisitions.

Genasys Inc. Director Lawrence F. Hagenbuch received a grant of 48,498 restricted stock units as part of director compensation.

Genasys Inc. Director William H. Dodd has acquired 47,620 restricted stock units, increasing his beneficial ownership to 176,783 shares.

Genasys Inc. Director William Craig Fugate acquired 47,620 restricted stock units, increasing his beneficial ownership.

Genasys Inc. Director R. Rimmy Malhotra received 47,620 restricted stock units, further aligning his interests with shareholders.

Genasys Inc. Director Susan Lee Schmeiser was granted 47,620 restricted stock units, increasing her beneficial ownership to 193,256 shares.

Genasys Inc. CEO Richard Danforth was granted 400,000 restricted stock units, aligning executive incentives with long-term company performance.

Genasys Inc. announces its virtual Annual Meeting of Stockholders on March 17, 2026, to elect directors, ratify auditors, and hold an advisory vote on executive compensation.

Genasys Inc. has filed a definitive proxy statement pursuant to Section 14(a) of the Securities Exchange Act of 1934.

Genasys Inc. has scheduled its 2025 Annual Meeting of Stockholders as a virtual event on March 17, 2025, and is seeking approval for a new equity incentive plan.